this post was submitted on 22 Jun 2026
1 points (100.0% liked)

China News

124 readers
17 users here now

A community for china news

founded 8 months ago
MODERATORS
 

China, which now conducts more clinical drug trials than the US, still lags in the quality and commercial reach of its biomedical science, according to a recent survey of senior US leaders in industry and academia. The ‌poll, conducted by Cure Innovation Index, found that China is seen as the clear leader in two out of six sectors: clinical development and supply chain. It found that the US leads in moving experimental products through to large-scale production, capital, and commercialisation...


From China - South China Morning Post via This RSS Feed.

you are viewing a single comment's thread
view the rest of the comments
[–] Zephyr@sh.itjust.works 1 points 9 hours ago

I'm slightly concerned none of the measures are efficacy, seems ever so slightly important.